Ji Yanli, Zhang A-Mei, Jia Xiaoyun, Zhang Ya-Ping, Xiao Xueshan, Li Shiqiang, Guo Xiangming, Bandelt Hans-Jürgen, Zhang Qingjiong, Yao Yong-Gang
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
Am J Hum Genet. 2008 Dec;83(6):760-8. doi: 10.1016/j.ajhg.2008.11.002. Epub 2008 Nov 20.
Leber hereditary optic neuropathy (LHON) is the most extensively studied mitochondrial disease, with the majority of the cases being caused by one of three primary mitochondrial DNA (mtDNA) mutations. Incomplete disease penetrance and gender bias are two features of LHON and indicate involvement of additional genetic or environmental factors in the pathogenesis of the disorder. Haplogroups J, K, and H have been shown to influence the clinical expression of LHON in subjects harboring primary mutations in European families. However, whether mtDNA haplogroups would affect the penetrance of LHON in East Asian families has not been evaluated yet. By studying the penetrance of LHON in 1859 individuals from 182 Chinese families (including one from Cambodia) with the m.11778G-->A mutation, we found that haplogroup M7b1'2 significantly increases the risk of visual loss, whereas M8a has a protective effect. Analyses of the complete mtDNA sequences from LHON families with m.11778G-->A narrow the association of disease expression to m.12811T-->C (Y159H) in the NADH dehydrogenase 5 gene (MT-ND5) in haplogroup M7b1'2 and suggest that the specific combination of amino acid changes (A20T-T53I) in the ATP synthase 6 protein (MT-ATP6) caused by m.8584G-->A and m.8684C-->T might account for the beneficial background effect of M8a. Protein secondary-structure prediction for the MT-ATP6 with the two M8a-specific amino acid changes further supported our inferences. These findings will assist in further understanding the pathogenesis of LHON and guide future genetic counseling in East Asian patients with m.11778G-->A.
Leber遗传性视神经病变(LHON)是研究最为广泛的线粒体疾病,大多数病例由三种主要线粒体DNA(mtDNA)突变之一引起。疾病不完全外显率和性别偏倚是LHON的两个特征,表明其他遗传或环境因素参与了该疾病的发病机制。在欧洲家族中,已证明单倍群J、K和H会影响携带原发性突变个体的LHON临床表型。然而,mtDNA单倍群是否会影响东亚家族中LHON的外显率尚未得到评估。通过研究182个中国家族(包括一个来自柬埔寨的家族)中1859名携带m.11778G→A突变个体的LHON外显率,我们发现单倍群M7b1'2显著增加了视力丧失的风险,而M8a具有保护作用。对携带m.11778G→A的LHON家族完整mtDNA序列的分析将疾病表达的关联缩小到单倍群M7b1'2中NADH脱氢酶5基因(MT-ND5)的m.12811T→C(Y159H),并表明由m.8584G→A和m.8684C→T引起的ATP合酶6蛋白(MT-ATP6)中特定氨基酸变化组合(A20T-T53I)可能是M8a产生有益背景效应的原因。对具有两种M8a特异性氨基酸变化的MT-ATP6进行蛋白质二级结构预测进一步支持了我们的推断。这些发现将有助于进一步了解LHON的发病机制,并指导东亚携带m.11778G→A突变患者的未来遗传咨询。